OPKO Health (OPK) Tops Q2 EPS by 1c
Tweet
Share
E-mail
Get Alerts OPK Hot Sheet
Price: $1.59 -3.05%
Revenue Growth %: -11.2%
Financial Fact:
Net loss attributable to common Shareholders: -14.98M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: -11.2%
Financial Fact:
Net loss attributable to common Shareholders: -14.98M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
OPKO Health (NASDAQ: OPK) reported Q2 EPS of ($0.04), $0.01 better than the analyst estimate of ($0.05). Revenue for the quarter came in at $314.2 million versus the consensus estimate of $322.64 million.
For earnings history and earnings-related data on OPKO Health (OPK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Casey's General Stores (CASY) Tops Q1 EPS by 69c
- Mission Produce (AVO) Misses Q3 EPS by 2c; offers outlook
- BMO Capital Starts Carter's (CRI) at Outperform
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
